TMC278
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for TMC278, covering 2012-11-27 to 2013-10-28. Get the full timeline:
Most recent: Clinical Trial Update: A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines [Phase 2]